オピオイド誘発性副作用治療の世界市場 2020年：企業別、地域別、種類・用途別

• 英文タイトル：Global Opioid Induced Side Effects Treatment Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：D0804-16287 • 出版社/出版日：GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、109ページ • 納品方法：Eメール • 産業分類：医薬品・治療

• 販売価格（消費税別）

Single User	￥487,200 (USD3,480)	▷ お問い合わせ
Multi User	￥730,800 (USD5,220)	▷ お問い合わせ
Corporate User	￥974,400 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、オピオイド誘発性副作用治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。オピオイド誘発性副作用治療の種類別市場規模（リスペリドン、メチルフェニデート、セチリジン、その他）、用途別市場規模（薬物過剰投与、痛み治療、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Shionogi、AstraZeneca、Cubist Pharmaceuticals、SLA Pharma、Progenics Pharmaceuticals、AIKO Biotechnology ・地域別グローバル市場分析 2015年-2020年 ・オピオイド誘発性副作用治療の北米市場（アメリカ、カナダ、メキシコ） ・オピオイド誘発性副作用治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・オピオイド誘発性副作用治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・オピオイド誘発性副作用治療の南米市場（ブラジル、アルゼンチン） ・オピオイド誘発性副作用治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：リスペリドン、メチルフェニデート、セチリジン、その他 ・用途別分析：薬物過剰投与、痛み治療、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論

Market Overview
The Opioid Induced Side Effects Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global Opioid Induced Side Effects Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

Market segmentation
Opioid Induced Side Effects Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Opioid Induced Side Effects Treatment market has been segmented into:
Risperidone
Methylphenidate
Cetirizine
Other

By Application, Opioid Induced Side Effects Treatment has been segmented into:
Drug Overdose Treatment
Pain Treatment
Other

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Opioid Induced Side Effects Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Opioid Induced Side Effects Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Opioid Induced Side Effects Treatment market.

The report offers in-depth assessment of the growth and other aspects of the Opioid Induced Side Effects Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Opioid Induced Side Effects Treatment Market Share Analysis
Opioid Induced Side Effects Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Opioid Induced Side Effects Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Opioid Induced Side Effects Treatment sales, revenue and market share for each player covered in this report.

The major players covered in Opioid Induced Side Effects Treatment are:
Shionogi
AstraZeneca
Cubist Pharmaceuticals
SLA Pharma
Progenics Pharmaceuticals
AIKO Biotechnology
Among other players domestic and global, Opioid Induced Side Effects Treatment market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

レポート目次

---

1 Opioid Induced Side Effects Treatment Market Overview
1.1 Product Overview and Scope of Opioid Induced Side Effects Treatment
1.2 Classification of Opioid Induced Side Effects Treatment by Type
1.2.1 Global Opioid Induced Side Effects Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Opioid Induced Side Effects Treatment Revenue Market Share by Type in 2019
1.2.3 Risperidone
1.2.4 Methylphenidate
1.2.5 Cetirizine
1.2.6 Other
1.3 Global Opioid Induced Side Effects Treatment Market by Application
1.3.1 Overview: Global Opioid Induced Side Effects Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Drug Overdose Treatment
1.3.3 Pain Treatment
1.3.4 Other
1.4 Global Opioid Induced Side Effects Treatment Market by Regions
1.4.1 Global Opioid Induced Side Effects Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Opioid Induced Side Effects Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Opioid Induced Side Effects Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Opioid Induced Side Effects Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Opioid Induced Side Effects Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Opioid Induced Side Effects Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Opioid Induced Side Effects Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 Shionogi
2.1.1 Shionogi Details
2.1.2 Shionogi Major Business
2.1.3 Shionogi SWOT Analysis
2.1.4 Shionogi Product and Services
2.1.5 Shionogi Opioid Induced Side Effects Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business
2.2.3 AstraZeneca SWOT Analysis
2.2.4 AstraZeneca Product and Services
2.2.5 AstraZeneca Opioid Induced Side Effects Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Cubist Pharmaceuticals
2.3.1 Cubist Pharmaceuticals Details
2.3.2 Cubist Pharmaceuticals Major Business
2.3.3 Cubist Pharmaceuticals SWOT Analysis
2.3.4 Cubist Pharmaceuticals Product and Services
2.3.5 Cubist Pharmaceuticals Opioid Induced Side Effects Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 SLA Pharma
2.4.1 SLA Pharma Details
2.4.2 SLA Pharma Major Business
2.4.3 SLA Pharma SWOT Analysis
2.4.4 SLA Pharma Product and Services
2.4.5 SLA Pharma Opioid Induced Side Effects Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Progenics Pharmaceuticals
2.5.1 Progenics Pharmaceuticals Details
2.5.2 Progenics Pharmaceuticals Major Business
2.5.3 Progenics Pharmaceuticals SWOT Analysis
2.5.4 Progenics Pharmaceuticals Product and Services
2.5.5 Progenics Pharmaceuticals Opioid Induced Side Effects Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 AIKO Biotechnology
2.6.1 AIKO Biotechnology Details
2.6.2 AIKO Biotechnology Major Business
2.6.3 AIKO Biotechnology Product and Services
2.6.4 AIKO Biotechnology Opioid Induced Side Effects Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Opioid Induced Side Effects Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Opioid Induced Side Effects Treatment Players Market Share
3.2.2 Top 10 Opioid Induced Side Effects Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Opioid Induced Side Effects Treatment Revenue and Market Share by Regions
4.2 North America Opioid Induced Side Effects Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Opioid Induced Side Effects Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Opioid Induced Side Effects Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Opioid Induced Side Effects Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Opioid Induced Side Effects Treatment Revenue and Growth Rate (2015-2020)
5 North America Opioid Induced Side Effects Treatment Revenue by Countries
5.1 North America Opioid Induced Side Effects Treatment Revenue by Countries (2015-2020)
5.2 USA Opioid Induced Side Effects Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Opioid Induced Side Effects Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Opioid Induced Side Effects Treatment Revenue and Growth Rate (2015-2020)
6 Europe Opioid Induced Side Effects Treatment Revenue by Countries
6.1 Europe Opioid Induced Side Effects Treatment Revenue by Countries (2015-2020)
6.2 Germany Opioid Induced Side Effects Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Opioid Induced Side Effects Treatment Revenue and Growth Rate (2015-2020)
6.4 France Opioid Induced Side Effects Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Opioid Induced Side Effects Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Opioid Induced Side Effects Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Opioid Induced Side Effects Treatment Revenue by Countries
7.1 Asia-Pacific Opioid Induced Side Effects Treatment Revenue by Countries (2015-2020)
7.2 China Opioid Induced Side Effects Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Opioid Induced Side Effects Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Opioid Induced Side Effects Treatment Revenue and Growth Rate (2015-2020)
7.5 India Opioid Induced Side Effects Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Opioid Induced Side Effects Treatment Revenue and Growth Rate (2015-2020)
8 South America Opioid Induced Side Effects Treatment Revenue by Countries
8.1 South America Opioid Induced Side Effects Treatment Revenue by Countries (2015-2020)
8.2 Brazil Opioid Induced Side Effects Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Opioid Induced Side Effects Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Opioid Induced Side Effects Treatment by Countries
9.1 Middle East & Africa Opioid Induced Side Effects Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Opioid Induced Side Effects Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Opioid Induced Side Effects Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Opioid Induced Side Effects Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Opioid Induced Side Effects Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Opioid Induced Side Effects Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Opioid Induced Side Effects Treatment Market Forecast by Type (2019-2024)
10.3 Risperidone Revenue Growth Rate (2015-2025)
10.4 Methylphenidate Revenue Growth Rate (2015-2025)
10.5 Cetirizine Revenue Growth Rate (2015-2025)
10.6 Other Revenue Growth Rate (2015-2025)
11 Global Opioid Induced Side Effects Treatment Market Segment by Application
11.1 Global Opioid Induced Side Effects Treatment Revenue Market Share by Application (2015-2020)
11.2 Opioid Induced Side Effects Treatment Market Forecast by Application (2019-2024)
11.3 Drug Overdose Treatment Revenue Growth (2015-2020)
11.4 Pain Treatment Revenue Growth (2015-2020)
11.5 Other Revenue Growth (2015-2020)
12 Global Opioid Induced Side Effects Treatment Market Size Forecast (2021-2025)
12.1 Global Opioid Induced Side Effects Treatment Market Size Forecast (2021-2025)
12.2 Global Opioid Induced Side Effects Treatment Market Forecast by Regions (2021-2025)
12.3 North America Opioid Induced Side Effects Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Opioid Induced Side Effects Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Opioid Induced Side Effects Treatment Revenue Market Forecast (2021-2025)
12.6 South America Opioid Induced Side Effects Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Opioid Induced Side Effects Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Opioid Induced Side Effects Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Opioid Induced Side Effects Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Opioid Induced Side Effects Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Opioid Induced Side Effects Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Opioid Induced Side Effects Treatment Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Shionogi Corporate Information, Location and Competitors
Table 7. Shionogi Opioid Induced Side Effects Treatment Major Business
Table 8. Shionogi Opioid Induced Side Effects Treatment Total Revenue (USD Million) (2017-2018)
Table 9. Shionogi SWOT Analysis
Table 10. Shionogi Opioid Induced Side Effects Treatment Product and Solutions
Table 11. Shionogi Opioid Induced Side Effects Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. AstraZeneca Corporate Information, Location and Competitors
Table 13. AstraZeneca Opioid Induced Side Effects Treatment Major Business
Table 14. AstraZeneca Opioid Induced Side Effects Treatment Total Revenue (USD Million) (2018-2019)
Table 15. AstraZeneca SWOT Analysis
Table 16. AstraZeneca Opioid Induced Side Effects Treatment Product and Solutions
Table 17. AstraZeneca Opioid Induced Side Effects Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Cubist Pharmaceuticals Corporate Information, Location and Competitors
Table 19. Cubist Pharmaceuticals Opioid Induced Side Effects Treatment Major Business
Table 20. Cubist Pharmaceuticals Opioid Induced Side Effects Treatment Total Revenue (USD Million) (2017-2018)
Table 21. Cubist Pharmaceuticals SWOT Analysis
Table 22. Cubist Pharmaceuticals Opioid Induced Side Effects Treatment Product and Solutions
Table 23. Cubist Pharmaceuticals Opioid Induced Side Effects Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. SLA Pharma Corporate Information, Location and Competitors
Table 25. SLA Pharma Opioid Induced Side Effects Treatment Major Business
Table 26. SLA Pharma Opioid Induced Side Effects Treatment Total Revenue (USD Million) (2017-2018)
Table 27. SLA Pharma SWOT Analysis
Table 28. SLA Pharma Opioid Induced Side Effects Treatment Product and Solutions
Table 29. SLA Pharma Opioid Induced Side Effects Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Progenics Pharmaceuticals Corporate Information, Location and Competitors
Table 31. Progenics Pharmaceuticals Opioid Induced Side Effects Treatment Major Business
Table 32. Progenics Pharmaceuticals Opioid Induced Side Effects Treatment Total Revenue (USD Million) (2017-2018)
Table 33. Progenics Pharmaceuticals SWOT Analysis
Table 34. Progenics Pharmaceuticals Opioid Induced Side Effects Treatment Product and Solutions
Table 35. Progenics Pharmaceuticals Opioid Induced Side Effects Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. AIKO Biotechnology Corporate Information, Location and Competitors
Table 37. AIKO Biotechnology Opioid Induced Side Effects Treatment Major Business
Table 38. AIKO Biotechnology Opioid Induced Side Effects Treatment Total Revenue (USD Million) (2017-2018)
Table 39. AIKO Biotechnology SWOT Analysis
Table 40. AIKO Biotechnology Opioid Induced Side Effects Treatment Product and Solutions
Table 41. AIKO Biotechnology Opioid Induced Side Effects Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Global Opioid Induced Side Effects Treatment Revenue (Million USD) by Players (2015-2020)
Table 43. Global Opioid Induced Side Effects Treatment Revenue Share by Players (2015-2020)
Table 44. Global Opioid Induced Side Effects Treatment Revenue (Million USD) by Regions (2015-2020)
Table 45. Global Opioid Induced Side Effects Treatment Revenue Market Share by Regions (2015-2020)
Table 46. North America Opioid Induced Side Effects Treatment Revenue by Countries (2015-2020)
Table 47. North America Opioid Induced Side Effects Treatment Revenue Market Share by Countries (2015-2020)
Table 48. Europe Opioid Induced Side Effects Treatment Revenue (Million USD) by Countries (2015-2020)
Table 49. Asia-Pacific Opioid Induced Side Effects Treatment Revenue (Million USD) by Countries (2015-2020)
Table 50. South America Opioid Induced Side Effects Treatment Revenue by Countries (2015-2020)
Table 51. South America Opioid Induced Side Effects Treatment Revenue Market Share by Countries (2015-2020)
Table 52. Middle East and Africa Opioid Induced Side Effects Treatment Revenue (Million USD) by Countries (2015-2020)
Table 53. Middle East and Africa Opioid Induced Side Effects Treatment Revenue Market Share by Countries (2015-2020)
Table 54. Global Opioid Induced Side Effects Treatment Revenue (Million USD) by Type (2015-2020)
Table 55. Global Opioid Induced Side Effects Treatment Revenue Share by Type (2015-2020)
Table 56. Global Opioid Induced Side Effects Treatment Revenue Forecast by Type (2021-2025)
Table 57. Global Opioid Induced Side Effects Treatment Revenue by Application (2015-2020)
Table 58. Global Opioid Induced Side Effects Treatment Revenue Share by Application (2015-2020)
Table 59. Global Opioid Induced Side Effects Treatment Revenue Forecast by Application (2021-2025)
Table 60. Global Opioid Induced Side Effects Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Opioid Induced Side Effects Treatment Picture
Figure 2. Global Opioid Induced Side Effects Treatment Revenue Market Share by Type in 2019
Figure 3. Risperidone Picture
Figure 4. Methylphenidate Picture
Figure 5. Cetirizine Picture
Figure 6. Other Picture
Figure 7. Opioid Induced Side Effects Treatment Revenue Market Share by Application in 2019
Figure 8. Drug Overdose Treatment Picture
Figure 9. Pain Treatment Picture
Figure 10. Other Picture
Figure 11. Global Opioid Induced Side Effects Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Opioid Induced Side Effects Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Opioid Induced Side Effects Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Opioid Induced Side Effects Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Opioid Induced Side Effects Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Opioid Induced Side Effects Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Opioid Induced Side Effects Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Opioid Induced Side Effects Treatment Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Opioid Induced Side Effects Treatment Revenue Market Share in 2019
Figure 20. Global Top 10 Players Opioid Induced Side Effects Treatment Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Opioid Induced Side Effects Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Opioid Induced Side Effects Treatment Revenue Market Share by Regions (2015-2020)
Figure 24. Global Opioid Induced Side Effects Treatment Revenue Market Share by Regions in 2018
Figure 25. North America Opioid Induced Side Effects Treatment Revenue and Growth Rate (2015-2020)
Figure 26. Europe Opioid Induced Side Effects Treatment Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Opioid Induced Side Effects Treatment Revenue and Growth Rate (2015-2020)
Figure 28. South America Opioid Induced Side Effects Treatment Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Opioid Induced Side Effects Treatment Revenue and Growth Rate (2015-2020)
Figure 30. North America Opioid Induced Side Effects Treatment Revenue Market Share by Countries (2015-2020)
Figure 31. North America Opioid Induced Side Effects Treatment Revenue Market Share by Countries in 2019
Figure 32. USA Opioid Induced Side Effects Treatment Revenue and Growth Rate (2015-2020)
Figure 33. Canada Opioid Induced Side Effects Treatment Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Opioid Induced Side Effects Treatment Revenue and Growth Rate (2015-2020)
Figure 35. Europe Opioid Induced Side Effects Treatment Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Opioid Induced Side Effects Treatment Revenue Market Share by Countries in 2019
Figure 37. Germany Opioid Induced Side Effects Treatment Revenue and Growth Rate (2015-2020)
Figure 38. UK Opioid Induced Side Effects Treatment Revenue and Growth Rate (2015-2020)
Figure 39. France Opioid Induced Side Effects Treatment Revenue and Growth Rate (2015-2020)
Figure 40. Russia Opioid Induced Side Effects Treatment Revenue and Growth Rate (2015-2020)
Figure 41. Italy Opioid Induced Side Effects Treatment Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Opioid Induced Side Effects Treatment Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Opioid Induced Side Effects Treatment Revenue Market Share by Countries in 2019
Figure 44. China Opioid Induced Side Effects Treatment Revenue and Growth Rate (2015-2020)
Figure 45. Japan Opioid Induced Side Effects Treatment Revenue and Growth Rate (2015-2020)
Figure 46. Korea Opioid Induced Side Effects Treatment Revenue and Growth Rate (2015-2020)
Figure 47. India Opioid Induced Side Effects Treatment Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Opioid Induced Side Effects Treatment Revenue and Growth Rate (2015-2020)
Figure 49. South America Opioid Induced Side Effects Treatment Revenue Market Share by Countries (2015-2020)
Figure 50. South America Opioid Induced Side Effects Treatment Revenue Market Share by Countries in 2019
Figure 51. Brazil Opioid Induced Side Effects Treatment Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Opioid Induced Side Effects Treatment Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Opioid Induced Side Effects Treatment Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Opioid Induced Side Effects Treatment Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Opioid Induced Side Effects Treatment Revenue and Growth Rate (2015-2020)
Figure 56. UAE Opioid Induced Side Effects Treatment Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Opioid Induced Side Effects Treatment Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Opioid Induced Side Effects Treatment Revenue and Growth Rate (2015-2020)
Figure 59. Global Opioid Induced Side Effects Treatment Revenue Share by Type (2015-2020)
Figure 60. Global Opioid Induced Side Effects Treatment Revenue Share by Type in 2019
Figure 61. Global Opioid Induced Side Effects Treatment Market Share Forecast by Type (2021-2025)
Figure 62. Global Risperidone Revenue Growth Rate (2015-2020)
Figure 63. Global Methylphenidate Revenue Growth Rate (2015-2020)
Figure 64. Global Cetirizine Revenue Growth Rate (2015-2020)
Figure 65. Global Other Revenue Growth Rate (2015-2020)
Figure 66. Global Opioid Induced Side Effects Treatment Revenue Share by Application (2015-2020)
Figure 67. Global Opioid Induced Side Effects Treatment Revenue Share by Application in 2019
Figure 68. Global Opioid Induced Side Effects Treatment Market Share Forecast by Application (2021-2025)
Figure 69. Global Drug Overdose Treatment Revenue Growth Rate (2015-2020)
Figure 70. Global Pain Treatment Revenue Growth Rate (2015-2020)
Figure 71. Global Other Revenue Growth Rate (2015-2020)
Figure 72. Global Opioid Induced Side Effects Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Opioid Induced Side Effects Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Opioid Induced Side Effects Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Opioid Induced Side Effects Treatment Revenue Market Forecast (2021-2025)
Figure 76. Europe Opioid Induced Side Effects Treatment Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Opioid Induced Side Effects Treatment Revenue Market Forecast (2021-2025)
Figure 78. South America Opioid Induced Side Effects Treatment Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Opioid Induced Side Effects Treatment Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel

---